These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 7024644

  • 1. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
    [No Abstract] [Full Text] [Related]

  • 2. NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.
    N Engl J Med; 1980 Oct 02; 303(14):831-2. PubMed ID: 6997737
    [No Abstract] [Full Text] [Related]

  • 3. Adjuvant chemotherapy of breast cancer. National Institutes of Health Consensus Development Conference Summary, Volume 3, Number 3.
    Oncol Nurs Forum; 1981 Oct 02; 8(1):7-9. PubMed ID: 7003562
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985 Oct 02; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract] [Full Text] [Related]

  • 5. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov 02; 44(11):721-3. PubMed ID: 7226778
    [No Abstract] [Full Text] [Related]

  • 6. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst Monogr; 2001 Nov 02; (30):5-15. PubMed ID: 11773285
    [Abstract] [Full Text] [Related]

  • 7. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.
    Lazovich D, Solomon CC, Thomas DB, Moe RE, White E.
    Cancer; 1999 Aug 15; 86(4):628-37. PubMed ID: 10440690
    [Abstract] [Full Text] [Related]

  • 8. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
    Cancer Control; 2001 Aug 15; 8(1):55. PubMed ID: 11176036
    [No Abstract] [Full Text] [Related]

  • 9. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2001 Aug 15; 17(4):1-35. PubMed ID: 11512506
    [Abstract] [Full Text] [Related]

  • 10. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD, Greenwald P.
    Semin Oncol; 1983 Sep 15; 10(3):360-4. PubMed ID: 6665563
    [No Abstract] [Full Text] [Related]

  • 11. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract] [Full Text] [Related]

  • 12. Clinical research. No lifeline for proposed breast cancer prevention trial.
    Kaiser J.
    Science; 2007 Jun 22; 316(5832):1679. PubMed ID: 17588904
    [No Abstract] [Full Text] [Related]

  • 13. Indications for neoadjuvant chemotherapy for breast cancer.
    Bear HD.
    Semin Oncol; 1998 Apr 22; 25(2 Suppl 3):3-12. PubMed ID: 9566201
    [No Abstract] [Full Text] [Related]

  • 14. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
    Newman LA, Mamounas EP.
    Surg Clin North Am; 2007 Apr 22; 87(2):279-305, vii. PubMed ID: 17498527
    [Abstract] [Full Text] [Related]

  • 15. Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.
    Edwards S.
    Find Brief; 2005 Jan 22; 8(1):1-3. PubMed ID: 15672527
    [No Abstract] [Full Text] [Related]

  • 16. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006 Jan 22; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 17. [A United States National Institutes of Health investigation suspended due to risk of breast cancer with use of hormone replacement in menopause].
    Zárate-Treviño A.
    Gac Med Mex; 2002 Jan 22; 138(6):595-6. PubMed ID: 12532629
    [No Abstract] [Full Text] [Related]

  • 18. Current status of adjuvant endocrine therapy for breast cancer.
    Ingle JN.
    Clin Cancer Res; 2001 Dec 22; 7(12 Suppl):4392s-4396s; discussion 4411s-4412s. PubMed ID: 11916230
    [Abstract] [Full Text] [Related]

  • 19. Some thoughts on the future of clinical trials in cancer.
    Wittes RE, Friedman MA, Simon R.
    Cancer Treat Rep; 1986 Feb 22; 70(2):241-50. PubMed ID: 2418968
    [No Abstract] [Full Text] [Related]

  • 20. Adjuvant chemotherapy for breast cancer. NIH consensus development conference, September 9-11, 1985.
    Cancer Treat Res; 1992 Feb 22; 60():375-82. PubMed ID: 1355999
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.